|
1
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View Article : Google Scholar
|
|
2
|
Pignon JP, le Maître A, Maillard E and
Bourhis J; MACH-NC Collaborative Group: Meta-analysis of
chemotherapy in head and neck cancer (MACH-NC): An update on 93
randomised trials and 17,346 patients. Radiother Oncol. 92:4–14.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bernier J, Domenge C, Ozsahin M,
Matuszewska K, Lefèbvre JL, Greiner RH, Giralt J, Maingon P,
Rolland F, Bolla M, et al: Postoperative irradiation with or
without concomitant chemo-therapy for locally advanced head and
neck cancer. N Engl J Med. 350:1945–1952. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cooper JS, Pajak TF, Forastiere AA, Jacobs
J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, et
al: Postoperative concurrent radiotherapy and chemotherapy for
high-risk squamous-cell carcinoma of the head and neck. N Engl J
Med. 350:1937–1944. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Agrawal N, Frederick MJ, Pickering CR,
Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, et
al: Exome sequencing of head and neck squamous cell carcinoma
reveals inactivating mutations in NOTCH1. Science. 333:1154–1157.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stransky N, Egloff AM, Tward AD, Kostic
AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C,
McKenna A, et al: The mutational landscape of head and neck
squamous cell carcinoma. Science. 333:1157–1160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun W, Gaykalova DA, Ochs MF, Mambo E,
Arnaoutakis D, Liu Y, Loyo M, Agrawal N, Howard J, Li R, et al:
Activation of the NOTCH pathway in head and neck cancer. Cancer
Res. 74:1091–1104. 2014. View Article : Google Scholar :
|
|
8
|
Kalaitzidis D and Armstrong SA: Cancer:
The flipside of Notch. Nature. 473:159–160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sethi N, Dai X, Winter CG and Kang Y:
Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast
cancer by engaging notch signaling in bone cells. Cancer Cell.
19:192–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zavadil J, Cermak L, Soto-Nieves N and
Bottinger EP: Integration of TGF-beta/Smad and Jagged1/Notch
signalling in epithelial-to-mesenchymal transition. EMBO J.
23:1155–1165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fischer A, Steidl C, Wagner TU, Lang E,
Jakob PM, Friedl P, Knobeloch KP and Gessler M: Combined loss of
Hey1 and HeyL causes congenital heart defects because of impaired
epithelial to mesenchymal transition. Circ Res. 100:856–863. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luna-Zurita L, Prados B, Grego-Bessa J,
Luxán G, del Monte G, Benguría A, Adams RH, Pérez-Pomares JM and de
la Pompa JL: Integration of a Notch-dependent mesenchymal gene
program and Bmp2-driven cell invasiveness regulates murine cardiac
valve formation. J Clin Invest. 120:3493–3507. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsung AJ, Guda MR, Asuthkar S, Labak CM,
Purvis IJ, Lu Y, Jain N, Bach SE, Prasad DVR and Velpula KK:
Methylation regulates HEY1 expression in glioblastoma. Oncotarget.
8:44398–44409. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shibata S, Marushima H, Asakura T,
Matsuura T, Eda H, Aoki K, Matsudaira H, Ueda K and Ohkawa K:
Three-dimensional culture using a radial flow bioreactor induces
matrix metalloprotease 7-mediated EMT-like process in tumor cells
via TGFbeta1/Smad pathway. Int J Oncol. 34:1433–1448.
2009.PubMed/NCBI
|
|
15
|
Man CH, Wei-Man Lun S, Wai-Ying Hui J, To
KF, Choy KW, Wing-Hung Chan A, Chow C, Tin-Yun Chung G, Tsao SW,
Tak-Chun Yip T, et al: Inhibition of NOTCH3 signalling
significantly enhances sensitivity to cisplatin in EBV-associated
nasopharyngeal carcinoma. J Pathol. 226:471–481. 2012. View Article : Google Scholar
|
|
16
|
Rettig EM, Bishop JA, Agrawal N, Chung CH,
Sharma R, Zamuner F, Li RJ, Koch WM, Califano JA, Guo T, et al:
HEY1 is expressed independent of NOTCH1 and is associated with poor
prognosis in head and neck squamous cell carcinoma. Oral Oncol.
82:168–175. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fukusumi T, Guo TW, Sakai A, Ando M, Ren
S, Haft S, Liu C, Amornphimoltham P, Gutkind JS and Califano JA:
The NOTCH4-HEY1 pathway induces epithelial-mesenchymal tran-sition
in head and neck squamous cell carcinoma. Clin Cancer Res.
24:619–633. 2018. View Article : Google Scholar
|
|
18
|
Fukusumi T, Ishii H, Konno M, Yasui T,
Nakahara S, Takenaka Y, Yamamoto Y, Nishikawa S, Kano Y, Ogawa H,
et al: CD10 as a novel marker of therapeutic resistance and cancer
stem cells in head and neck squamous cell carcinoma. Br J Cancer.
111:506–514. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Prince ME, Sivanandan R, Kaczorowski A,
Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles
LE: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen YC, Chen YW, Hsu HS, Tseng LM, Huang
PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, et al: Aldehyde
dehydrogenase 1 is a putative marker for cancer stem cells in head
and neck squamous cancer. Biochem Biophys Res Commun. 385:307–313.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee SH, Oh SY, Do SI, Lee HJ, Kang HJ, Rho
YS, Bae WJ and Lim YC: SOX2 regulates self-renewal and
tumorigenicity of stem-like cells of head and neck squamous cell
carcinoma. Br J Cancer. 111:2122–2130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Du L, Yang Y, Xiao X, Wang C, Zhang X,
Wang L, Zhang X, Li W, Zheng G, Wang S and Dong Z: Sox2 nuclear
expression is closely associated with poor prognosis in patients
with histo-logically node-negative oral tongue squamous cell
carcinoma. Oral Oncol. 47:709–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang N, Hui L, Wang Y, Yang H and Jiang X:
Overexpression of SOX2 promotes migration, invasion, and
epithelial-mesenchymal transition through the Wnt/β-catenin pathway
in laryngeal cancer Hep-2 cells. Tumour Biol. 35:7965–7973. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Han XY, Wei B, Fang JF, Zhang S, Zhang FC,
Zhang HB, Lan TY, Lu HQ and Wei HB: Epithelial-mesenchymal
transition associates with maintenance of stemness in
spheroid-derived stem-like colon cancer cells. PLoS One.
8:e733412013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gangemi RM, Griffero F, Marubbi D, Perera
M, Capra MC, Malatesta P, Ravetti GL, Zona GL, Daga A and Corte G:
SOX2 silencing in glioblastoma tumor-initiating cells causes stop
of proliferation and loss of tumorigenicity. Stem Cells. 27:40–48.
2009. View Article : Google Scholar
|
|
27
|
Han X, Fang X, Lou X, Hua D, Ding W, Foltz
G, Hood L, Yuan Y and Lin B: Silencing SOX2 induced
mesenchymal-epithelial transition and its expression predicts liver
and lymph node metastasis of CRC patients. PLoS One. 7:e413352012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Boumahdi S, Driessens G, Lapouge G, Rorive
S, Nassar D, Le Mercier M, Delatte B, Caauwe A, Lenglez S, Nkusi E,
et al: SOX2 controls tumour initiation and cancer stem-cell
functions in squamous-cell carcinoma. Nature. 511:246–250. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Seo E, Basu-Roy U, Zavadil J, Basilico C
and Mansukhani A: Distinct functions of Sox2 control self-renewal
and differentiation in the osteoblast lineage. Mol Cell Biol.
31:4593–4608. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Salmon-Divon M, Dvinge H, Tammoja K and
Bertone P: PeakAnalyzer: Genome-wide annotation of chromatin
binding and modification loci. BMC Bioinformatics. 11:4152010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leal MC, Surace EI, Holgado MP, Ferrari
CC, Tarelli R, Pitossi F, Wisniewski T, Castano EM and Morelli L:
Notch signaling proteins HES-1 and Hey-1 bind to insulin degrading
enzyme (IDE) proximal promoter and repress its transcription and
activity: Implications for cellular Aβ metabolism. Biochim Biophys
Acta. 1823:227–235. 2012. View Article : Google Scholar
|
|
32
|
Iso T, Sartorelli V, Poizat C, Iezzi S, Wu
HY, Chung G, Kedes L and Hamamori Y: HERP, a novel heterodimer
partner of HES/E(spl) in Notch signaling. Mol Cell Biol.
21:6080–6089. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Joo YH, Jung CK, Kim MS and Sun DI:
Relationship between vascular endothelial growth factor and Notch1
expression and lymphatic metastasis in tongue cancer. Otolaryngol
Head Neck Surg. 140:512–518. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang TH, Liu HC, Zhu LJ, Chu M, Liang YJ,
Liang LZ and Liao GQ: Activation of Notch signaling in human tongue
carcinoma. J Oral Pathol Med. 40:37–45. 2011. View Article : Google Scholar
|
|
35
|
Lim YC, Oh SY, Cha YY, Kim SH, Jin X and
Kim H: Cancer stem cell traits in squamospheres derived from
primary head and neck squamous cell carcinomas. Oral Oncol.
47:83–91. 2011. View Article : Google Scholar
|
|
36
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brabletz T, Kalluri R, Nieto MA and
Weinberg RA: EMT in cancer. Nat Rev Cancer. 18:128–134. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shao K, Chen ZY, Gautam S, Deng NH, Zhou Y
and Wu XZ: Posttranslational modification of E-cadherin by core
fucosylation regulates Src activation and induces
epithelial-mesenchymal transition-like process in lung cancer
cells. Glycobiology. 26:142–154. 2016. View Article : Google Scholar
|
|
39
|
Vanner RJ, Remke M, Gallo M, Selvadurai
HJ, Coutinho F, Lee L, Kushida M, Head R, Morrissy S, Zhu X, et al:
Quiescent sox2(+) cells drive hierarchical growth and relapse in
sonic hedgehog subgroup medulloblastoma. Cancer Cell. 26:33–47.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pan W, Jin Y, Stanger B and Kiernan AE:
Notch signaling is required for the generation of hair cells and
supporting cells in the mammalian inner ear. Proc Natl Acad Sci
USA. 107:15798–15803. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Benito-Gonzalez A and Doetzlhofer A: Hey1
and Hey2 control the spatial and temporal pattern of mammalian
auditory hair cell differentiation downstream of Hedgehog
signaling. J Neurosci. 34:12865–12876. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fang KM, Lin TC, Chan TC, Ma SZ, Tzou BC,
Chang WR, Liu JJ, Chiou SH, Yang CS and Tzeng SF: Enhanced cell
growth and tumorigenicity of rat glioma cells by stable expression
of human CD133 through multiple molecular actions. Glia.
61:1402–1417. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen JY, Li CF, Chu PY, Lai YS, Chen CH,
Jiang SS, Hou MF and Hung WC: Lysine demethylase 2A promotes
stemness and angiogenesis of breast cancer by upregulating Jagged1.
Oncotarget. 7:27689–27710. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang J, Xu SL, Duan JJ, Yi L, Guo YF, Shi
Y, Li L, Yang ZY, Liao XM, Cai J, et al: Invasion of white matter
tracts by glioma stem cells is regulated by a NOTCH1-SOX2
positive-feedback loop. Nat Neurosci. 22:91–105. 2019. View Article : Google Scholar
|
|
45
|
Ehm O, Göritz C, Covic M, Schäffner I,
Schwarz TJ, Karaca E, Kempkes B, Kremmer E, Pfrieger FW, Espinosa
L, et al: RBPJkappa-dependent signaling is essential for long-term
maintenance of neural stem cells in the adult hippocampus. J
Neurosci. 30:13794–13807. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu X, Yao J, Wang L, Zhang D, Zhang L,
Reynolds EX, Yu T, Bostrom KI and Yao Y: Crosstalk between BMP and
Notch induces Sox2 in cerebral endothelial cells. Cells. 8:5492019.
View Article : Google Scholar :
|
|
47
|
Ferone G, Song JY, Sutherland KD,
Bhaskaran R, Monkhorst K, Lambooij JP, Proost N, Gargiulo G and
Berns A: SOX2 is the determining oncogenic switch in promoting lung
squamous cell carcinoma from different cells of origin. Cancer
Cell. 30:519–532. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bochen F, Adisurya H, Wemmert S, Lerner C,
Greiner M, Zimmermann R, Hasenfus A, Wagner M, Smola S, Pfuhl T, et
al: Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis
and clinical outcome of head and neck squamous cell carcinomas.
Oncotarget. 8:4922–4934. 2017. View Article : Google Scholar :
|
|
49
|
Forghanifard MM, Taleb S and Abbaszadegan
MR: Notch signaling target genes are directly correlated to
esophageal squamous cell carcinoma tumorigenesis. Pathol Oncol Res.
21:463–467. 2015. View Article : Google Scholar
|
|
50
|
James AC, Szot JO, Iyer K, Major JA,
Pursglove SE, Chapman G and Dunwoodie SL: Notch4 reveals a novel
mechanism regulating Notch signal transduction. Biochim Biophys
Acta. 1843:1272–1284. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fukusumi T and Califano JA: The NOTCH
pathway in head and neck squamous cell carcinoma. J Dent Res.
97:645–65. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yu S, Zhang R, Liu F, Hu H, Yu S and Wang
H: Down-regulation of Notch signaling by a γ-secretase inhibitor
enhances the radio-sensitivity of nasopharyngeal carcinoma cells.
Oncol Rep. 26:1323–1328. 2011.PubMed/NCBI
|
|
53
|
Zhao ZL, Zhang L, Huang CF, Ma SR, Bu LL,
Liu JF, Yu GT, Liu B, Gutkind JS, Kulkarni AB, et al: NOTCH1
inhibition enhances the efficacy of conventional chemotherapeutic
agents by targeting head neck cancer stem cell. Sci Rep.
6:247042016. View Article : Google Scholar : PubMed/NCBI
|
